openPR Logo
Press release

Australia Age-Related Macular Degeneration Market | Worth USD 239.47 Million 2026-2034

01-30-2026 08:43 AM CET | Health & Medicine

Press release from: IMARC Group

Australia Age-Related Macular Degeneration Market | Worth USD

Market Overview

The Australia age-related macular degeneration market reached USD 209.12 Million in 2025 and is projected to grow to USD 239.47 Million by 2034. The forecast period spans from 2026 to 2034 with an anticipated CAGR of 1.52%. Key growth drivers include Australia's rapidly aging population, enhanced government reimbursement policies, and advancements in artificial intelligence enabling early diagnosis and disease monitoring. These factors collectively boost treatment accessibility and expand the market share. For more detailed information, visit the Australia Age-Related Macular Degeneration Market

How AI is Reshaping the Future of Australia Age-Related Macular Degeneration Market

• Advanced deep learning algorithms analyze optical coherence tomography scans and color fundus photographs with diagnostic accuracy comparable or superior to human experts.

• AI models predict disease progression, optimize treatment intervals for anti-VEGF injections, and enable early automated screening programs, enhancing disease management.

• AI-enabled remote monitoring addresses geographic disparities by facilitating access to quality eye care in rural and remote Australian populations.

• Telemedicine platforms incorporating AI diagnostic tools enable preliminary AMD screening in primary care or community health centers, improving early specialist referrals.

• A qualitative study by UNSW Sydney with 37 stakeholders revealed increasing acceptability and anticipated fee-for-service models for AI-driven remote monitoring of neovascular AMD.

• Successful AI integration requires algorithm validation, transparent system communication, ongoing clinical oversight, and robust data governance to ensure ethical deployment.

Grab a sample PDF of this report: https://www.imarcgroup.com/australia-age-related-macular-degeneration-market/requestsample

Market Growth Factors

The Australian market is propelled by a rapidly aging population, reshaping healthcare demands for age-related conditions like macular degeneration, which affects about 1.25 million Australians over 50. This figure is expected to rise to 1.7 million as more enter higher-risk age groups. The Australian Bureau of Statistics projects that by 2066, nearly 25% of Australians will be aged 65 or older, significantly increasing the at-risk demographic. This demographic shift drives demand for diagnostic services, anti-VEGF therapies, and specialized ophthalmic care, prompting healthcare systems to expand capacity and implement comprehensive eye screening programs across metropolitan and regional areas.

Government policies and reimbursement schemes strongly support market expansion. The National Strategic Action Plan for Macular Disease launched in 2022 coordinates national efforts to improve service delivery, research funding, and patient support, notably enhancing diagnostic availability in rural and underserved regions. Meanwhile, the Pharmaceutical Benefits Scheme subsidizes anti-VEGF drugs like Lucentis, Eylea, Beovu, and Vabysmo, reducing out-of-pocket costs for patients and improving treatment affordability. Ongoing collaborations between federal and state health departments aim to expand hospital eye injection clinics to manage rising demand while maintaining high treatment standards.

Artificial intelligence technologies fundamentally transform AMD diagnosis and management, offering accuracy comparable to expert clinicians through machine learning analysis of retinal imaging. AI helps predict disease progression, optimize injection intervals, and support personalized regimens, decreasing unnecessary visits and improving healthcare resource allocation. AI-based remote screening and monitoring particularly benefit Australia's rural and remote populations by mitigating geographic healthcare disparities. However, successful integration depends on validated algorithms, transparency in limitations, human clinical oversight, and strong data governance frameworks ensuring ethical and privacy-compliant use.

Browse the full report with TOC and list of figures: https://www.imarcgroup.com/australia-age-related-macular-degeneration-market

Market Segmentation

Analysis by Product:

• Eylea

• Lucentis

• Beovu

• Others

Analysis by Disease Type:

• Wet Age-related Macular Degeneration

• Dry Age-related Macular Degeneration

Analysis by Region:

• Australia Capital Territory & New South Wales

• Victoria & Tasmania

• Queensland

• Northern Territory & Southern Australia

• Western Australia

Key Players

• BenoBio

Recent Developement & News

• July 2025: The Australian government reinforced its commitment to combating macular disease by expanding the National Strategic Action Plan, resulting in improved diagnostic service availability in rural and underserved regions, thereby increasing early detection and treatment accessibility.

• March 2025: BenoBio commenced a Phase I dose-escalation clinical trial of BBRP11001 targeting neovascular AMD patients resistant to conventional anti-VEGF therapies. This initiative reflects pharmaceutical innovation responding to unmet treatment needs and growing patient demand.

• October 2025: Pharmaceutical Benefits Scheme updates continued to subsidize anti-VEGF medications, ensuring affordability for both concession and general beneficiaries despite potential private insurance coverage changes, supporting sustained patient adherence and broad market growth.

Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Ask an analyst for your customized sample: https://www.imarcgroup.com/request?type=report&id=44015&flag=C

Contact Us

IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201-971-6302

About Us

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Australia Age-Related Macular Degeneration Market | Worth USD 239.47 Million 2026-2034 here

News-ID: 4370384 • Views:

More Releases from IMARC Group

Hydrogen Fluoride Manufacturing Plant DPR 2026: Investment Cost, Market Growth & ROI
Hydrogen Fluoride Manufacturing Plant DPR 2026: Investment Cost, Market Growth & …
Setting up a hydrogen fluoride manufacturing plant positions investors within a strategically important segment of the global specialty chemicals and fluorochemicals industry, driven by increasing demand for semiconductor manufacturing, refrigerant production, and pharmaceutical intermediates. As modern industrial processes advance, electronics manufacturing expands, and the need for high-purity fluorine compounds grows, hydrogen fluoride continues to gain traction across semiconductor fabrication, aluminum production, and petroleum refining worldwide. Rising demand from high-tech industries,
Vinyl Acetate Ethylene Production Plant Cost 2026: Industry Overview and Profitability Assessment
Vinyl Acetate Ethylene Production Plant Cost 2026: Industry Overview and Profita …
Setting up a Vinyl Acetate Ethylene Production Plant positions investors in one of the most stable and essential segments of the specialty chemicals and polymer value chain, backed by sustained global growth driven by growing construction activity, rising demand for high-performance dry-mix mortars, increasing use in paints and coatings, and the dual-benefit advantages of delivering flexible, low-VOC polymer binder solutions that meet both industrial performance standards and evolving environmental compliance
Fluff Pulp Manufacturing Plant DPR & Unit Setup - 2026: Machinery Cost, CapEx/OpEx, ROI, Raw Materials
Fluff Pulp Manufacturing Plant DPR & Unit Setup - 2026: Machinery Cost, CapEx/Op …
Setting up a fluff pulp manufacturing plant positions investors within a strategically important segment of the global hygiene products and absorbent materials industry, driven by increasing demand for disposable hygiene products, absorbent personal care items, and medical applications. As consumer hygiene standards advance, disposable product adoption expands, and the need for high-quality absorbent materials grows, fluff pulp continues to gain traction across baby diapers, adult incontinence products, feminine hygiene items,
Fire Alarms Manufacturing Plant DPR & Unit Setup - 2026: Demand Analysis and Project
Fire Alarms Manufacturing Plant DPR & Unit Setup - 2026: Demand Analysis and Pro …
Setting up a fire alarms manufacturing plant positions investors within a strategically important segment of the global safety and security equipment industry, driven by increasing demand for fire detection and safety systems, stringent building safety regulations, and growing awareness of fire protection measures. As modern construction practices advance, smart building integration expands, and the need for advanced fire safety infrastructure grows, fire alarms continue to gain traction across commercial buildings,

All 5 Releases


More Releases for Australia

Derila Memory foam pillow Australia: Honest Reviews About Derila Australia
Derila is one of the best memory foam pillows sold in Australia today. Priced at around 30 dollars (USD), derila is currently the most reviewed and the cheapest memory pillow available in Australia. What is Derila? Is Derila Pillow the best in Australia? Keep reading to discover everything worth knowing about Derila Australia. OVERVIEW Recently, Memory foam pillow has been trending and there is a lot of brands to choose from. Which one is
CeraCare Australia - Where to Buy Legit CeraCare Supplement in Australia?
CeraCare Australia - Ceracare is a glucose support supplement that proposes to augment cardiovascular prosperity and to stay aware of perfect glucose assimilation in Australia. CeraCare supplement is conceptualized and executed by a threesome – Christine, Dr. Jihn and Michael. It is a natural supplement that helps one stay aware of ideal glucose levels, cardiovascular prosperity, and glucose assimilation. Take Advantage of 80% Discount Offer in Australia >> https://boostsxproaustralia.com/ceracare-new The indications
Glucofort Australia - Where to Buy Legit Glucofort Supplement in Australia?
Glucofort Australia - Glucofort is an efficient, all-natural progressive glucose support supplement in Australia. This formula is made out of 12 key ingredients, 7 nutrients, and minerals, and a little of Vanadium. This supplement upholds regulated glucose levels and glucose digestion. Glucofort prides itself as the most inventive supplements available in Oceania, accentuating its solidarity, wellbeing, and quality. Take Advantage of 75% Discount Offer in Australia >> https://boostsxproaustralia.com/glucofort-new Rather than simply
Australia Agriculture Market, Australia Agriculture Industry, Australia Agricult …
Australia Agriculture has been as vital within the development of Australia, because it was within the United States. Australia's ancient dominance in wheat and sheep continues into the 21st century. Recently Australian agriculture has become more and more diversified. The considerable expanses of productive land have helped Australia to become a number one world exporter of grains, meats, and wool. Each grains (predominantly wheat and barley) and wool markets round
Australia Conveyor Maintenance Analysis by Top Companies Habasit Australia Pty l …
Global Australia Conveyor Maintenance Market and Competitive Analysis Know your current market situation! Not only a vital element for brand new products but also for current products given the ever-changing market dynamics. The study allows marketers to remain involved with current consumer trends and segments where they'll face a rapid market share drop. Discover who you actually compete against within the marketplace, with Market Share Analysis know market position, to push
Australia Conveyor Maintenance Market Analysis By Manufacturers Rema Tip Top Aus …
A conveyor system is a common piece of mechanical handling device that moves materials/objects from one location. A conveyor is often lifeline to a company’s ability to effectively move its products in a timely manner. While it is used constantly in a manufacturing plant, proper maintenance from trained technicians can extend the lifespan of conveyor. Furthermore, conveyor maintenance is essential as it may be subjected to different types of failures